Differences between hospitals in attainment of parathyroid hormone treatment targets in chronic kidney disease do not reflect differences in quality of care
<p>Abstract</p> <p>Background</p> <p>Transparency in quality of care (QoC) is stimulated and hospitals are compared and judged on the basis of indicators of performance on specific treatment targets. In patients with chronic kidney disease, QoC differed significantly be...
Main Authors: | Peeters Mieke J, van Zuilen Arjan D, AJG van den Brand Jan, Blankestijn Peter J, AGJ ten Dam Marc, FM Wetzels Jack |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-08-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2369/13/82 |
Similar Items
-
Parathyroid carcinoma survival: improvements in the era of intact parathyroid hormone monitoring?
by: Steve R. Martinez, et al.
Published: (2013-02-01) -
Disparity between Preoperative and Pre-Excisional Intraoperative Parathyroid Hormone in Parathyroid Surgery
by: Maheer M. Masood, et al.
Published: (2018-03-01) -
Intraoperative parathyroid hormone assay-cutting the Gordian knot
by: Chandralekha Tampi, et al.
Published: (2014-01-01) -
Intraoperative parathyroid hormone monitoring in guiding adequate parathyroidectomy
by: Aabid Hassan Naik, et al.
Published: (2018-01-01) -
Modified quick parathyroid hormone test in surgery of primary hyperparathyroidism
by: I. V. Sleptsov, et al.
Published: (2015-12-01)